These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25650695)

  • 41. Retinol-binding protein-4 and hs-CRP levels in patients with migraine.
    Tanik N; Celikbilek A; Metin A; Gocmen AY; Inan LE
    Neurol Sci; 2015 Oct; 36(10):1823-7. PubMed ID: 26012852
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Possible resting metabolic rate modification by the circulating RBP4 in obese subjects.
    Ansar H; Mirzaei K; Malek A; Najmafshar A; Hossein-nezhad A
    Diabetes Metab Syndr; 2015; 9(1):19-23. PubMed ID: 25450816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retinol binding protein-4 circulating levels were higher in nonalcoholic fatty liver disease vs. histologically normal liver from morbidly obese women.
    Terra X; Auguet T; Broch M; Sabench F; Hernández M; Pastor RM; Quesada IM; Luna A; Aguilar C; del Castillo D; Richart C
    Obesity (Silver Spring); 2013 Jan; 21(1):170-7. PubMed ID: 23505183
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adalimumab in the treatment of moderate-to-severe chronic plaque psoriasis in patients switching from other biologics.
    Sator P; Richter L; Saxinger W; Vasiljevic M; Stingl G
    J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1742-9. PubMed ID: 25665143
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of psoriasis with adalimumab.
    Pitarch G; Sanchez-Carazo JL; Mahiques L; Perez-Ferriols MA; Fortea JM
    Clin Exp Dermatol; 2007 Jan; 32(1):18-22. PubMed ID: 17305904
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Depot-specific expression of retinol-binding protein 4 in human adipose tissue and their relationship with obesity and insulin resistance].
    Lu HY; Li XF; Mu PW; Jiang W; Zeng LY
    Zhonghua Yi Xue Za Zhi; 2010 Dec; 90(48):3395-8. PubMed ID: 21223811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased RBP4 in a human model of activated anti-atherosclerotic and antiremodelling defences.
    Calò LA; Maiolino G; Pagnin E; Vertolli U; Davis PA
    Eur J Clin Invest; 2014 Jun; 44(6):567-72. PubMed ID: 24739026
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis.
    Revicki DA; Willian MK; Menter A; Gordon KB; Kimball AB; Leonardi CL; Langley RG; Kimel M; Okun M
    J Dermatolog Treat; 2007; 18(6):341-50. PubMed ID: 18058494
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Retinol-binding protein 4 as a novel risk factor for cardiovascular disease in patients with coronary artery disease and hyperinsulinemia.
    Li F; Xia K; Li C; Yang T
    Am J Med Sci; 2014 Dec; 348(6):474-9. PubMed ID: 25233041
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism.
    Hahn S; Backhaus M; Broecker-Preuss M; Tan S; Dietz T; Kimmig R; Schmidt M; Mann K; Janssen OE
    Eur J Endocrinol; 2007 Aug; 157(2):201-7. PubMed ID: 17656599
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum retinol-binding protein 4 correlates with obesity, insulin resistance, and dyslipidemia in HIV-infected subjects receiving highly active antiretroviral therapy.
    Han SH; Chin BS; Lee HS; Jeong SJ; Choi HK; Kim CO; Choi JY; Song YG; Lee HC; Kim JM
    Metabolism; 2009 Nov; 58(11):1523-9. PubMed ID: 19501863
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment effect of adalimumab and infliximab in Japanese psoriasis patients: results in a single community-based hospital.
    Noda S; Mizuno K; Adachi M
    J Dermatol; 2012 Mar; 39(3):265-8. PubMed ID: 22126280
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1.
    Petta S; Cammà C; Di Marco V; Alessi N; Barbaria F; Cabibi D; Caldarella R; Ciminnisi S; Licata A; Massenti MF; Mazzola A; Tarantino G; Marchesini G; Craxì A
    Hepatology; 2008 Jul; 48(1):28-37. PubMed ID: 18506842
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes in insulin resistance and cardiovascular risk induced by PPARgamma activation have no impact on RBP4 plasma concentrations in nondiabetic patients.
    Pfützner A; Schöndorf T; Hanefeld M; Lübben G; Kann PH; Karagiannis E; Wilhelm B; Forst T
    Horm Metab Res; 2009 Mar; 41(3):202-6. PubMed ID: 19224430
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris.
    Gniadecki R; Kragballe K; Dam TN; Skov L
    Br J Dermatol; 2011 May; 164(5):1091-6. PubMed ID: 21219290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Leptin, adiponectin, visfatin and retinol-binding protein-4 - mediators of comorbidities in patients with psoriasis?
    Gerdes S; Osadtschy S; Rostami-Yazdi M; Buhles N; Weichenthal M; Mrowietz U
    Exp Dermatol; 2012 Jan; 21(1):43-7. PubMed ID: 22151390
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis.
    Gordon KB; Duffin KC; Bissonnette R; Prinz JC; Wasfi Y; Li S; Shen YK; Szapary P; Randazzo B; Reich K
    N Engl J Med; 2015 Jul; 373(2):136-44. PubMed ID: 26154787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of tumor necrosis factor alpha (TNF α) antagonists in a patient with psoriasis and Chagas disease.
    Navarrete-Dechent C; Majerson D; Torres M; Armijo D; Patel M; Menter A; de la Cruz C
    An Bras Dermatol; 2015; 90(3 Suppl 1):171-4. PubMed ID: 26312707
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patients achieving clearance of HCV with interferon therapy recover from decreased retinol-binding protein 4 levels.
    Iwasa M; Hara N; Miyachi H; Tanaka H; Takeo M; Fujita N; Kobayashi Y; Kojima Y; Kaito M; Takei Y
    J Viral Hepat; 2009 Oct; 16(10):716-23. PubMed ID: 19302338
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of serum retinol-binding protein 4 with insulin resistance and metabolic parameters during olanzapine therapy.
    Faghihi T; Radfar M; Abdoli E; Amini H; Hemami MR; Larijani B
    Clin Endocrinol (Oxf); 2012 Feb; 76(2):207-11. PubMed ID: 21711373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.